Clinical Trials Directory

Trials / Sponsors / Castle Creek Biosciences, LLC.

Castle Creek Biosciences, LLC.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingEvaluation of D-Fi for the Treatment of Wounds Due to DEB
Dystrophic Epidermolysis Bullosa
Phase 32025-03-27
Active Not RecruitingA Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
Recessive Dystrophic Epidermolysis Bullosa
Phase 32020-06-09
TerminatedA Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)
Morphea, Scleroderma, Localized, Scleroderma
Phase 1 / Phase 22019-12-18
TerminatedA Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Epidermolysis Bullosa Dystrophica, Recessive
Phase 1 / Phase 22016-07-01
CompletedControlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysp
Dysphonia Resulting From Vocal Fold Scarring, Age-related Dysphonia
Phase 22014-03-01
TerminatedPilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Restrictive Burn Scars
Phase 22013-05-01
WithdrawnPilot Safety and Efficacy Study of Isolagen Therapy in Treatment of Restrictive Burn Scars
Restrictive Burn Scars of Joint Area
Phase 22008-02-01
CompletedSafety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne Scarring
Acne Scarring of the Face
Phase 2 / Phase 32007-11-01
CompletedSafety and Efficacy Study of Isolagen TherapyTM in Treatment of Facial Wrinkles and Creases
Facial Wrinkles and Creases
Phase 22007-03-01
CompletedSafety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles
Bilateral Nasolabial Fold Wrinkles
Phase 32006-11-01
CompletedSafety and Efficacy Study of Isolagen TherapyTM in the Treatment of Nasolabial Fold Wrinkles
Bilateral Nasolabial Fold Wrinkles
Phase 32006-10-01
CompletedSafety and Efficacy Study of Isolagen TherapyTM in Treatment of Interdental Papillary Insufficiency
Interdental Papillary Insufficiency
Phase 22006-01-01